OZ-101

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameOZ-101
Drug Alias NameOZ-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel blockers
TargetsPotassium channel
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOzstar Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesOzstar Therapeutics
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A